CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)	3 Months Ended	9 Months Ended
Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenue
Total revenue	$ 167,280,410	$ 97,134,281	$ 414,451,683	$ 263,782,043
Expenses
Cost of services	96,828,245	66,736,945	281,721,686	192,951,753
General and administrative expenses	9,032,024	4,380,878	31,481,810	15,434,640
Depreciation and amortization	4,843,037	4,764,783	14,819,627	14,407,113
Total expenses	110,703,306	75,882,606	328,023,123	222,793,506
Income from operations	56,577,104	21,251,675	86,428,560	40,988,537
Other income (expense)
Loss from equity method investments	(4,215,056)	(1,461,096)	(2,573,219)	(28,936)
Interest expense	(178,318)	(14,984)	(374,002)	(16,370)
Interest income	343,369	226,864	953,003	618,641
Change in fair value of derivative instruments	0	(406,665)	0	(278,886)
Other income	684,283	94,471	1,112,935	122,609
Total other income (expense), net	(3,365,722)	(1,561,410)	(881,283)	417,058
Income before provision for income taxes	53,211,382	19,690,265	85,547,277	41,405,595
Provision for income taxes	14,585,942	7,865,902	23,338,589	16,491,982
Net income	38,625,440	11,824,363	62,208,688	24,913,613
Net income attributable to noncontrolling interest	29,519,043	6,203,991	48,277,734	12,948,837
Net income attributable to Apollo Medical Holdings, Inc.	$ 9,106,397	$ 5,620,372	$ 13,930,954	$ 11,964,776
Earnings per share - basic	$ 0.28	$ 0.22	$ 0.43	$ 0.48
Earnings per share - diluted	$ 0.24	$ 0.20	$ 0.37	$ 0.42
Weighted average shares of common stock outstanding-basic	32,917,007	25,067,954	32,672,793	25,067,954
Weighted average shares of common stock outstanding - diluted	38,387,700	28,417,877	38,010,838	28,417,877
Capitation, net [Member]
Revenue
Total revenue	$ 90,612,720	$ 66,130,166	$ 266,834,186	$ 193,725,886
Health Care, Other [Member]
Revenue
Total revenue	57,788,932	21,498,540	89,641,885	40,994,338
Management Service [Member]
Revenue
Total revenue	12,851,178	6,449,329	37,297,358	19,274,141
Health Care, Patient Service [Member]
Revenue
Total revenue	5,665,053	2,729,295	19,092,631	8,437,756
Product and Service, Other [Member]
Revenue
Total revenue	$ 362,527	$ 326,951	$ 1,585,623	$ 1,349,922

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Name:	us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.